CCL2 and renal fibrosis: Our results indicated that the administration of MA inhibits the expression of pro-inflammatory cytokines and cell adhesion molecules such as IL-1β, TNF-α, MCP-1, and ICAM-1, suggesting that MA may ameliorate renal fibrosis by the inhibition of inflammatory response.